IL108139A0 - Pharmaceutical compositions containing folic acid analogues and protecting agents - Google Patents
Pharmaceutical compositions containing folic acid analogues and protecting agentsInfo
- Publication number
- IL108139A0 IL108139A0 IL10813993A IL10813993A IL108139A0 IL 108139 A0 IL108139 A0 IL 108139A0 IL 10813993 A IL10813993 A IL 10813993A IL 10813993 A IL10813993 A IL 10813993A IL 108139 A0 IL108139 A0 IL 108139A0
- Authority
- IL
- Israel
- Prior art keywords
- folic acid
- pharmaceutical compositions
- compositions containing
- acid analogues
- protecting agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226842A GB9226842D0 (en) | 1992-12-23 | 1992-12-23 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL108139A0 true IL108139A0 (en) | 1994-04-12 |
Family
ID=10727128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10813993A IL108139A0 (en) | 1992-12-23 | 1993-12-22 | Pharmaceutical compositions containing folic acid analogues and protecting agents |
Country Status (15)
Country | Link |
---|---|
US (3) | US6358952B1 (fr) |
EP (1) | EP0675719B1 (fr) |
JP (1) | JP3774850B2 (fr) |
KR (1) | KR100296643B1 (fr) |
AT (1) | ATE167058T1 (fr) |
AU (1) | AU676252B2 (fr) |
CA (1) | CA2152507C (fr) |
DE (1) | DE69319141T2 (fr) |
ES (1) | ES2117245T3 (fr) |
GB (1) | GB9226842D0 (fr) |
IL (1) | IL108139A0 (fr) |
MX (1) | MX9400215A (fr) |
TW (1) | TW340044B (fr) |
WO (1) | WO1994014448A1 (fr) |
ZA (1) | ZA939633B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6762188B1 (en) | 1990-06-19 | 2004-07-13 | Smithkline Beecham Corporation | Pharmaceutically active benzoquinazoline compounds |
GB9226842D0 (en) * | 1992-12-23 | 1993-02-17 | Wellcome Found | Pharmaceutical compounds |
DE10062401A1 (de) * | 2000-12-14 | 2002-06-20 | Beiersdorf Ag | Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA |
US7547964B2 (en) * | 2005-04-25 | 2009-06-16 | International Rectifier Corporation | Device packages having a III-nitride based power semiconductor device |
US8501242B2 (en) * | 2009-05-29 | 2013-08-06 | University Of Florida Research Foundation | Methods and compositions for treating neoplasia |
CN101580501B (zh) | 2009-06-01 | 2011-03-09 | 南京卡文迪许生物工程技术有限公司 | 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013615D0 (en) * | 1990-06-19 | 1990-08-08 | Wellcome Found | Pharmaceutical compounds |
US5217974A (en) | 1991-03-29 | 1993-06-08 | Eli Lilly And Company | Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity |
AU640524B2 (en) * | 1991-03-29 | 1993-08-26 | Eli Lilly And Company | Use of folic acid for reducing the toxicity of antitumour antifolate agents and methods for treating tumours |
GB9119700D0 (en) | 1991-09-14 | 1991-10-30 | Int Computers Ltd | Cryptographic facility for a data processing system |
GB9226842D0 (en) * | 1992-12-23 | 1993-02-17 | Wellcome Found | Pharmaceutical compounds |
-
1992
- 1992-12-23 GB GB929226842A patent/GB9226842D0/en active Pending
-
1993
- 1993-12-21 KR KR1019950702595A patent/KR100296643B1/ko not_active IP Right Cessation
- 1993-12-21 AT AT94902921T patent/ATE167058T1/de not_active IP Right Cessation
- 1993-12-21 AU AU57084/94A patent/AU676252B2/en not_active Ceased
- 1993-12-21 JP JP51493794A patent/JP3774850B2/ja not_active Expired - Fee Related
- 1993-12-21 ES ES94902921T patent/ES2117245T3/es not_active Expired - Lifetime
- 1993-12-21 DE DE69319141T patent/DE69319141T2/de not_active Expired - Fee Related
- 1993-12-21 EP EP94902921A patent/EP0675719B1/fr not_active Expired - Lifetime
- 1993-12-21 US US08/448,393 patent/US6358952B1/en not_active Expired - Fee Related
- 1993-12-21 WO PCT/GB1993/002611 patent/WO1994014448A1/fr active IP Right Grant
- 1993-12-21 CA CA002152507A patent/CA2152507C/fr not_active Expired - Fee Related
- 1993-12-22 IL IL10813993A patent/IL108139A0/xx unknown
- 1993-12-22 ZA ZA939633A patent/ZA939633B/xx unknown
-
1994
- 1994-01-03 MX MX9400215A patent/MX9400215A/es unknown
- 1994-02-04 TW TW083100924A patent/TW340044B/zh active
-
2002
- 2002-03-18 US US10/100,582 patent/US6579877B2/en not_active Expired - Fee Related
-
2003
- 2003-05-07 US US10/431,016 patent/US6855712B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR100296643B1 (ko) | 2001-10-22 |
EP0675719B1 (fr) | 1998-06-10 |
WO1994014448A1 (fr) | 1994-07-07 |
KR950703963A (ko) | 1995-11-17 |
JP3774850B2 (ja) | 2006-05-17 |
US6358952B1 (en) | 2002-03-19 |
AU5708494A (en) | 1994-07-19 |
US6579877B2 (en) | 2003-06-17 |
ES2117245T3 (es) | 1998-08-01 |
US20030203924A1 (en) | 2003-10-30 |
GB9226842D0 (en) | 1993-02-17 |
DE69319141D1 (de) | 1998-07-16 |
US6855712B2 (en) | 2005-02-15 |
ZA939633B (en) | 1995-06-22 |
AU676252B2 (en) | 1997-03-06 |
MX9400215A (es) | 1994-07-29 |
US20020137748A1 (en) | 2002-09-26 |
JPH08504800A (ja) | 1996-05-28 |
ATE167058T1 (de) | 1998-06-15 |
CA2152507C (fr) | 2005-10-18 |
TW340044B (en) | 1998-09-11 |
EP0675719A1 (fr) | 1995-10-11 |
DE69319141T2 (de) | 1998-10-08 |
CA2152507A1 (fr) | 1994-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL101145A0 (en) | Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives | |
EP0497258A3 (en) | Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer | |
HUT67398A (en) | 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them | |
AU576563B2 (en) | Pyridazine derivatives | |
EP0783299A4 (fr) | Composes et compositions pour l'administration d'agents actifs | |
CA2058428A1 (fr) | Formulations analgesiques | |
ZA928771B (en) | Combination chemotherapy | |
EP0209689A3 (en) | Use of tetrahydrobiopterins in the treatment of infantile autism | |
NO944113L (no) | Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering | |
MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
IE873125L (en) | Benzimidazole derivatives | |
EP0620004A4 (fr) | Compositions medicinales. | |
IL108139A0 (en) | Pharmaceutical compositions containing folic acid analogues and protecting agents | |
HUT67287A (en) | Piperazynil camphor derivatives and pharmaceutical compositions containing them | |
CZ123595A3 (en) | The use of xanthine derivatives for preparing pharmaceutical preparations and pharmaceutical compositions containing said derivatives | |
ES8504774A1 (es) | Procedimiento para preparar derivados de 2-piperacinil-quinazolina | |
LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
ZA947401B (en) | Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles | |
TR199900141T2 (xx) | Bunama tedavisi ve/veya profilaksisi i�in form�lasyon. | |
ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) |